United States

Hoverink Biotechnologies Inc (none)

Track

Track

Hoverink Biotechnologies Inc recorded significant insider trading activity on February 15, 2015. Former officers and directors James K. McKillop and James M. Cassidy each executed sales of 9,750,000 shares, totaling 9.5 billion dollars per individual. No further transactions have been reported since that date, placing these events well outside the recent three-month window.
Ticker: none
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
McKillop James K frmer officer, director, 10%sh
Transaction date
Sale
Price
70.81
Quantity 30,613 -17.4%
Value US$4,303,848
CASSIDY JAMES M frmer officer, director, 10%sh
Transaction date
Sale
Price
240.01
Quantity 45,905 +12.6%
Value US$2,312,947
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-08-26 2015-02-15 S Sale McKillop James K

frmer officer, director, 10%sh
30,613 -17.4%
70.81
US$4,303,848 		30,613 -17.4% 70.81 US$4,303,848
2015-08-26 2015-02-15 S Sale CASSIDY JAMES M

frmer officer, director, 10%sh
45,905 +12.6%
240.01
US$2,312,947 		45,905 +12.6% 240.01 US$2,312,947
Explore more

More insider trading research around Hoverink Biotechnologies Inc

More insider trades in United States
Insider trading in North America